Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2019 · 10-Q
Revenue$165.88M$165.88M+68.2% vs Q1 2018 Net Income$20.75M$20.75M+69.8% vs Q1 2018 EPS Diluted$1.70$1.70+68.3% vs Q1 2018 Gross Profit$125,147,000+67.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$32,734,000+81.8% Free Cash Flowderived$28,290,000+69.2% Margins · derivedGross margin75.4%−0.4 pt vs Q1 2018
Operating margin14.9%+0.0 pt vs Q1 2018
Net margin12.5%+0.1 pt vs Q1 2018
ended Mar 31, 2019 · filed May 2, 2019 · 32 d after period end